Home > Financial Ratios > AURO LABORATORIES

AURO LABORATORIES
Core EBITDA Growth

    Back to All Ratios
AURO LABORATORIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AURO LABORATORIES
Please provide your vote to see the results

AURO LABORATORIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 128.22-6.71-52.3565.67-8.91

What is the latest Core EBITDA Growth ratio of AURO LABORATORIES ?

The latest Core EBITDA Growth ratio of AURO LABORATORIES is 128.22 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024128.22
Mar2023-6.71
Mar2022-52.35
Mar202165.67
Mar2020-8.91

How is Core EBITDA Growth of AURO LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 128.22
Positive
Mar2023 -6.71
Negative
Mar2022 -52.35
Negative
Mar2021 65.67
Positive
Mar2020 -8.91 -

Other Financial Ratios of AURO LABORATORIES


Compare Core EBITDA Growth ratio of peers of AURO LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AURO LABORATORIES ₹179.0 Cr 9.3% 10.2% 64.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,667.0 Cr 1.8% 3.4% 7.3% Stock Analytics
DIVIS LABORATORIES ₹180,131.0 Cr -0.7% 3.8% 49.3% Stock Analytics
CIPLA ₹119,745.0 Cr -0.2% -1.1% -2.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹118,603.0 Cr 5.8% 8.6% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,429.0 Cr 0.7% -3.8% -7.3% Stock Analytics


AURO LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AURO LABORATORIES

9.3%

10.2%

64.8%

SENSEX

-1.1%

0.8%

2.2%


You may also like the below Video Courses